by Radiological Society of North America Comparison of cerebral blood flow in 65 cognitively normal midlife individuals showed that individuals with obesity and high visceral adipose tissue have reduced blood flow in the temporal and parietal regions of the brain. Credit: Radiological Society of North America (RSNA) and Mahsa Dolatshahi, M.D., M.P.H. Researchers have linked a...
Post
Pediatrician explains whooping cough
by Shreya Doshi, MD, MBBS Credit: Pixabay/CC0 Public Domain Whooping cough, or pertussis, is a highly contagious respiratory infection caused by bacteria called Bordetella pertussis. The infection attacks the lining of the breathing passages. People can get whooping cough any time of year, but generally infections are seen in late summer and fall. Symptoms of...
Post
Salmonella outbreak triggers recall of cucumbers in 26 states
by Robin Foster Sixty-eight people have been sickened and 18 have been hospitalized in a salmonella outbreak linked to whole cucumbers sold in 26 states and parts of Canada. “Epidemiologic and traceback information shows that cucumbers grown by Agrotato, S.A. de C.V. in Sonora, Mexico, including recalled cucumbers from SunFed Produce LLC, may be contaminated...
Post
Tips for coping with an anxiety disorder
by Siri Kabrick, Mayo Clinic Credit: Kelvin Valerio from Pexels Having occasional feelings of anxiety is a normal part of life, but people with anxiety disorders experience frequent and excessive anxiety, fear, terror and panic in everyday situations. These feelings are unhealthy if they affect your quality of life and prevent you from functioning normally. Common...
Post
Immune system DNA may hold key for multiple personalized disease therapies
by Umea University A specific protein in human lung cells can block the SARS-CoV-2 virus from entering. Photo: Umeå University Some people naturally have higher levels of proteins that protect them from COVID-19. New studies at Umeå University of our immune system may pave the way for more personalized treatments of both COVID-19 and autoimmune disorders....
Post
Diabetes Drug Class May Reduce Need for Gout Medications
Miriam E. Tucker November 19, 2024 0155 Added to Email Alert WASHINGTON, DC — Use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduced the need for urate-lowering therapy (ULT) and gout flare therapies in people who had both type 2 diabetes (T2D) and gout, new research has found. Data from a large US claims database showed that...
Post
AI Robot Ultrasound Scanning System Found to Be as Good as Rheumatologists at Assessing RA
Miriam E. Tucker November 25, 2024 184 Added to Email Alert WASHINGTON — A fully automated ultrasound scanning system combined with artificial intelligence–based disease activity scoring performed as well as expert rheumatologists in hand joint assessment of patients with rheumatoid arthritis (RA), new research found. The system, made by a Danish company called ROPCA, comprises an ultrasound scanner...
Post
Semaglutide Rocketing Past Statins as Millions Eligible
Alicia Ault November 27, 2024 0178 Added to Email Alert About 40% of American adults — some 137 million — are eligible to take the glucagon-like peptide 1 (GLP-1) receptor agonist semaglutide, said authors of a new study. Currently, statins are the most commonly prescribed medication for American adults, with some 192 million prescriptions written...
Post
When Patients Don’t Show Up: The Hidden Cost of Missed Appointments
Lambeth Hochwald November 15, 2024 6125 Added to Email Alert For decades, no-show patients have proven to be a costly problem for physicians. In fact, missed appointments lead to a staggering $150 billion impact on the US healthcare system annually. The reasons patients opt out of appointments are as individual as the patient and include concerns about...
Post
GLP-1 RA Drug Class Benefits People With SLE, Lupus Nephritis
Miriam E. Tucker November 26, 2024 115 Added to Email Alert WASHINGTON — Glucagon-like peptide 1 receptor agonist (GLP-1 RA) medications appear beneficial for people with systemic lupus erythematosus (SLE) and lupus nephritis, two new studies suggest. “The risk of cardiovascular disease is thought to be at least double that for people with lupus…and we...